What we do
From 2021 to 2025, the project will:
- Develop and apply innovative sampling, sample preparation and analytics to assess internal (human matrices) and external (abiotic) exposure to MNP.
- Develop and apply a human-based in vitro toolbox for testing epithelial transfer and immunotoxicity of MNP
- Assess exposure and biological effects of MNP in real-life scenarios
- Establish a risk assessment strategy and execute HRA for MNP
- Manage data for current use in developing MNP risk assessment strategy and for future in silico predictions
- Exchange and communicate information and knowledge to our stakeholders